Q2 2015 13F Holders as of 6/30/2015
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
170M
-
Number of holders
-
186
-
Total 13F shares, excl. options
-
97.4M
-
Shares change
-
+945K
-
Total reported value, excl. options
-
$4.08B
-
Value change
-
+$68M
-
Put/Call ratio
-
1.05
-
Number of buys
-
90
-
Number of sells
-
-96
-
Price
-
$41.88
Significant Holders of ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) as of Q2 2015
241 filings reported holding ACAD - ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value as of Q2 2015.
ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) has 186 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 97.4M shares
of 170M outstanding shares and own 57.26% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (20.5M shares), FMR LLC (15M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.63M shares), VANGUARD GROUP INC (5.3M shares), OPPENHEIMER FUNDS INC (3.78M shares), Capital World Investors (3.42M shares), BlackRock Fund Advisors (3.21M shares), JANUS CAPITAL MANAGEMENT LLC (3.02M shares), JENNISON ASSOCIATES LLC (2.52M shares), and FRANKLIN RESOURCES INC (2.48M shares).
This table shows the top 186 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.